Knoll Capital Management, LLC
Long book
$180.2M
Q1 2026
Positions
37
Top-10 weight
62%
concentration
Last quarter
-1.3%
SPY +14.8%
Turnover
29%
of book per quarter
Strategy in plain words
auto-generated from filingsKnoll Capital Management, LLC is a concentrated fundamental stock-picker, running a $180.2M US long book across 37 positions.
The portfolio is concentrated: the top 10 names carry 62% of the portfolio. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: BIOHAVEN PHARMACEUTICAL HOLD, SPROTT PHYSICAL GOLD TRUST, ROYAL GOLD INC, MEIRAGTX HOLDINGS PLC, AGNICO EAGLE MINES LTD.
Over the last 9 quarters its long book ran on average 1.4pp per quarter ahead of the S&P 500, beating the index in 4 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-0.3%
Q2 2024
+23.0%
Q3 2024
-2.2%
Q4 2024
+7.5%
Q1 2025
-2.0%
Q2 2025
+29.3%
Q3 2025
+10.2%
Q4 2025
-11.1%
Q1 2026
-1.3%
Sector allocation
Materials 39%
Healthcare 30%
Financials 16%
Other 12%
Consumer staples 1%
Technology 1%
Services media 1%
Industrials 0%
Long book by quarter
What does Knoll Capital own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| BHVNEUR BIOHAVEN PHARMACEUTICAL HOLD | — | 2.3M | $19.7M | 10.9% | Held |
| RGLD ROYAL GOLD INC | Financials | 52.8K | $13.4M | 7.5% | Held |
| MGTX MEIRAGTX HOLDINGS PLC | Healthcare | 1.3M | $10.8M | 6.0% | Held |
| AEM AGNICO EAGLE MINES LTD | Materials | 52.8K | $10.7M | 5.9% | Held |
| KGC KINROSS GOLD CORP | Materials | 320.0K | $9.8M | 5.4% | -22.0% |
| ALDX ALDEYRA THERAPEUTICS INC | Healthcare | 5.5M | $9.3M | 5.1% | Held |
| SA SEABRIDGE GOLD INC | Materials | 317.0K | $9.0M | 5.0% | Held |
| FNV FRANCO-NEVADA CORP | Materials | 32.0K | $7.9M | 4.4% | +28.0% |
| SSRM SSR MINING INC | Financials | 245.0K | $7.2M | 4.0% | Held |
| ELTX ELICIO THERAPEUTICS INC | Healthcare | 630.9K | $6.7M | 3.7% | Held |
| ENTX ENTERA BIO LTD | Healthcare | 5.9M | $6.5M | 3.6% | Held |
| NUVB NUVATION BIO INC | Healthcare | 1.5M | $6.4M | 3.6% | Held |
| CGAU CENTERRA GOLD INC | Materials | 359.0K | $6.4M | 3.5% | -27.8% |
| PAAS PAN AMERICAN SILVER CORP | Materials | 100.0K | $5.5M | 3.0% | Held |
| OCUL OCULAR THERAPEUTIX INC | Healthcare | 600.4K | $5.1M | 2.8% | Held |
| TFPM TRIPLE FLAG PRECIOUS MET | Financials | 115.0K | $4.0M | 2.2% | +95.6% |
| GROY GOLD ROYALTY CORP | Materials | 1.0M | $3.6M | 2.0% | New |
| AGI ALAMOS GOLD INC-CLASS A | Materials | 50.0K | $2.2M | 1.2% | Held |
| ABEO ABEONA THERAPEUTICS INC | Healthcare | 485.5K | $2.2M | 1.2% | +105.8% |
| NEWP NEW PACIFIC METALS CORP | Materials | 485.0K | $2.0M | 1.1% | Held |
| CDE COEUR MINING INC | Materials | 96.1K | $1.8M | 1.0% | Held |
| PM PHILIP MORRIS INTERNATIONAL | Consumer staples | 10.0K | $1.7M | 0.9% | Held |
| WPM WHEATON PRECIOUS METALS CORP | Materials | 12.5K | $1.6M | 0.9% | Held |
| NOC NORTHROP GRUMMAN CORP | Technology | 2.2K | $1.5M | 0.8% | Held |
| BAH BOOZ ALLEN HAMILTON HOLDINGS | Services media | 13.0K | $1.0M | 0.6% | Held |
| ELE ELEMENTAL ROYALTY CORP | Materials | 50.0K | $943K | 0.5% | New |
| VMET VERSAMET ROYALTIES CORP | Financials | 66.6K | $634K | 0.4% | New |
| DC DAKOTA GOLD CORP | Materials | 122.9K | $621K | 0.3% | Held |
| AMRZ AMRIZE LTD | Industrials | 9.2K | $514K | 0.3% | New |
| ALT ALTIMMUNE INC | Healthcare | 160.0K | $493K | 0.3% | -85.7% |
| CRDL CARDIOL THERAPEUTICS INC-A | Healthcare | 100.0K | $135K | 0.1% | Held |
| OR OR ROYALTIES INC | Materials | 225.0K | $9K | 0.0% | New |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 37 | $180.2M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 34 | $218.0M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 39 | $186.6M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 38 | $140.7M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 36 | $153.7M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 18, 2025 | 35 | $155.3M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 36 | $215.8M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 35 | $148.4M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 34 | $160.7M | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP